ATCC®

Quantitated Nucleic Acids – Empowering Molecular-based Assay Development

Molecular diagnostics are increasingly relied upon to direct appropriate therapies for the personalized treatment of cancer patients as well as to identify, track, and quantify pathogenic microorganisms. To ensure the reliability and reproducibility of these assays, authenticated controls with confirmed identity, stability, and functionality are required. In the following webinar, Dr. Tian and Ms. Long discusses ATCC's growing portfolio of quantitative nucleic acids that support oncology molecular diagnostic assays, infectious disease research, and quality control testing.

*
*
*
*
*
*